The whiplash over a new potential flu vaccine from Moderna, which went from rejected to approved for review in a matter of days, has illustrated a new reality plaguing the Cambridge biotech company ...

President Trump mixed up two different Black Caribbean countries at a Black History Month event at the White House on ...

Bhattacharya will continue his role as the director of National Institutes of Health, as well as lead the CDC on an acting ...

When family members criticize me publicly, I don’t see betrayal. I see adversity. And adversity is instruction.” ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

The director of the National Institutes of Health is also taking over as acting head of the Centers for Disease Control and Prevention, according to an administration official ...

Two Iowa nursing homes cited for resident abuse and dozens of other regulatory violations have been added to the federal government’s list of the nation’s worst ...

The FDA will now review Moderna’s seasonal mRNA influenza vaccine application, setting a mid-2026 decision date.

In a regulatory filing on Wednesday, Moderna said the Food and Drug Administration will review a late-stage trial for the company’s first-ever flu shot and set an August deadline to approve or deny ...

Kennedy Jr., the entire federal public-health apparatus was assembled in the spirit of Covid resentment, which, more than any ...

RFK Jr.'s attacks on vaccines go beyond changing the childhood immunization schedule. Now he's taking aim at vaccine R&D itself.

Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults ...